Gene · 4176
Papers3,001
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 3,001
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer. | BMC Cancer | 2021 | 34404366 | PubTator, text mining | PubMed |
| Integrative oncogene-dependency mapping identifies RIT1 vulnerabilities and synergies in lung cancer. | Nat Commun | 2021 | 34373451 | PubTator, text mining | PubMed |
| Establishment of a Three-Dimensional In Vitro Model of Equine Papillomavirus Type 2 Infection. | Viruses | 2021 | 34372610 | PubTator, text mining | PubMed |
| A novel cell-cycle-regulated interaction of the Bloom syndrome helicase BLM with Mcm6 controls replication-linked processes. | Nucleic Acids Res | 2021 | 34370039 | PubTator, text mining | PubMed |
| The Fate of Two Unstoppable Trains After Arriving Destination: Replisome Disassembly During DNA Replication Termination. | Front Cell Dev Biol | 2021 | 34368118 | PubTator, text mining | PubMed |
| Multi-Omic Analyses of the m5C Regulator ALYREF Reveal Its Essential Roles in Hepatocellular Carcinoma. | Front Oncol | 2021 | 34367948 | PubTator, text mining | PubMed |
| Transcriptomics-Based Phenotypic Screening Supports Drug Discovery in Human Glioblastoma Cells. | Cancers (Basel) | 2021 | 34359681 | PubTator, text mining | PubMed |
| Deep computational analysis details dysregulation of eukaryotic translation initiation complex eIF4F in human cancers. | Cell Syst | 2021 | 34358439 | PubTator, text mining | PubMed |
| Effect of ISM1 on the Immune Microenvironment and Epithelial-Mesenchymal Transition in Colorectal Cancer. | Front Cell Dev Biol | 2021 | 34350177 | PubTator, text mining | PubMed |
| Sulfamethoxazole-Altered Transcriptomein Green Alga Raphidocelis subcapitata Suggests Inhibition of Translation and DNA Damage Repair. | Front Microbiol | 2021 | 34349730 | PubTator, text mining | PubMed |
| The DNA-binding protein CST associates with the cohesin complex and promotes chromosome cohesion. | J Biol Chem | 2021 | 34339741 | PubTator, text mining | PubMed |
| Developmental lineage of human pluripotent stem cell-derived cardiac fibroblasts affects their functional phenotype. | FASEB J | 2021 | 34339055 | PubTator, text mining | PubMed |
| A novel class of inhibitors that target SRSF10 and promote p53-mediated cytotoxicity on human colorectal cancer cells. | NAR Cancer | 2021 | 34316707 | PubTator, text mining | PubMed |
| HSP90 inhibition downregulates DNA replication and repair genes via E2F1 repression. | J Biol Chem | 2021 | 34302809 | PubTator, text mining | PubMed |
| Imidazoles as Potential Anticancer Agents: An Update on Recent Studies. | Molecules | 2021 | 34299488 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Antiproliferative and Apoptosis Activity by 1,5-Bis(4-Hydroxy-3-Methoxyphenyl)1,4-Pentadiene-3-one (MS13) on Human Non-Small Cell Lung Cancer Cells. | Int J Mol Sci | 2021 | 34299042 | PubTator, text mining | PubMed |
| NR5A2 Is One of 12 Transcription Factors Predicting Prognosis in HNSCC and Regulates Cancer Cell Proliferation in a p53-Dependent Manner. | Front Oncol | 2021 | 34277436 | PubTator, text mining | PubMed |
| An Update on the Potential Roles of E2F Family Members in Colorectal Cancer. | Cancer Manag Res | 2021 | 34276228 | PubTator, text mining | PubMed |
| MCM-2, Ki-67, and EGFR downregulated expression levels in advanced stage laryngeal squamous cell carcinoma. | Sci Rep | 2021 | 34272446 | PubTator, text mining | PubMed |
| Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies. | PLoS One | 2021 | 34270554 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4176/papers?page=35